Activist 13D/13G Filings - Growth Equity Opportunities Fund IV LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-08-28
9:51 pm
Sale
13DVerona Pharma plc
VRNA
Growth Equity Opportunities Fund IV LLC44,678,025
6.900%
-1,769,626decrease
(-3.81%)
View
2024-08-14
8:12 pm
Sale
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC0
0.000%
-6,624,600decrease
(Position Closed)
View
2024-08-05
9:00 pm
Sale
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC6,624,600
5.100%
-1,080,000decrease
(-14.02%)
View
2023-12-08
2:11 pm
Purchase
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
6.400%
7,704,600increase
(New Position)
View
2023-04-10
4:06 pm
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
8.500%
0
(Unchanged)
View
2022-11-28
3:19 pm
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
9.700%
0
(Unchanged)
View
2022-11-01
5:01 pm
Sale
13DAVEO PHARMACEUTICALS INC
AVEO
Growth Equity Opportunities Fund IV LLC0
0.000%
-5,424,009decrease
(Position Closed)
View
2022-09-07
5:28 pm
Purchase
13DVerona Pharma plc
VRNA
Growth Equity Opportunities Fund IV LLC46,447,651
7.900%
3,809,520increase
(+8.93%)
View
2022-08-23
5:18 pm
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
15.100%
0
(Unchanged)
View
2022-01-10
1:15 pm
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
20.400%
0
(Unchanged)
View
2021-04-21
5:28 pm
Sale
13DAffimed N.V.
AFMD
Growth Equity Opportunities Fund IV LLC0
0.000%
-6,126,488decrease
(Position Closed)
View
2021-01-21
6:47 pm
Purchase
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
21.500%
7,704,600increase
(New Position)
View
2020-08-03
4:18 pm
Purchase
13DVerona Pharma plc
VRNA
Growth Equity Opportunities Fund IV LLC42,638,131
10.200%
31,111,112increase
(+269.90%)
View
2020-06-24
5:03 pm
Sale
13DAVEO PHARMACEUTICALS INC
AVEO
Growth Equity Opportunities Fund IV LLC5,424,009
20.800%
-34,530,377decrease
(-86.42%)
View
2019-11-18
1:52 pm
Purchase
13DAffimed N.V.
AFMD
Growth Equity Opportunities Fund IV LLC6,126,488
8.200%
987,600increase
(+19.22%)
View